mifepristone has been researched along with Cancer of Endometrium in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (29.03) | 18.2507 |
2000's | 15 (48.39) | 29.6817 |
2010's | 4 (12.90) | 24.3611 |
2020's | 3 (9.68) | 2.80 |
Authors | Studies |
---|---|
Abd Jamil, AH; Chung, I; Mat Adenan, NA; Omar, IS | 1 |
Chung, I; Godoy, A; Gunasagran, Y; Mat Adenan, NA; Omar, IS; Teo, IH | 1 |
Hong, L; Qian, M; Wu, Q; Zhang, L | 1 |
Metsis, M; Salumets, A; Simm, J; Suhorutshenko, M; Tamm-Rosenstein, K | 1 |
Li, MJ; Lu, ZZ; Yan, L; Zhang, H; Zhang, XH; Zhao, XX | 1 |
Grønaas, H; Moe, BT; Paulssen, RH; Ørbo, A | 1 |
Moe, BG; Orbo, A; Sager, G; Vereide, AB | 1 |
Jaeger, R; Moe, BT; Orbo, A; Sager, G; Vereide, AB | 1 |
Amazit, L; Bellance, C; Guiochon-Mantel, A; Khan, JA; Lombès, M; Loosfelt, H | 1 |
Bouchard, P | 1 |
Chao, V; Dreher, E; Mueller, MD; Pritts, EA; Taylor, RN; Vigne, JL | 1 |
Lan, SM; Li, CZ; Liu, Y; Wang, JY; Wen, ZQ | 1 |
Archer, DF; Mirkin, S | 1 |
Chen, CL; Liao, QP; Lu, Y; Yu, L | 2 |
Amezcua, CA; Felix, JC; Jain, JK; Li, A; Minoo, P | 1 |
Bamberger, AM; Briese, J; Erdmann, I; Götze, J; Nollau, P; Schulte, HM; Wagener, C | 1 |
Brown, J; Burke, T; Gaikwad, A; Navo, MA; Ramondetta, LM; Smith, JA | 1 |
Gravanis, A; Makrigiannakis, A; Margioris, AN; Stournaras, C | 1 |
Falany, CN; Falany, JL | 1 |
Bamberger, AM; Bamberger, CM; Gellersen, B; Schulte, HM | 1 |
Chrousos, GP; Gravanis, A; Makrigiannakis, A; Margioris, AN; Stournaras, C; Zoumakis, E | 1 |
Castelbaum, AJ; Chwalisz, K; Ilesanmi, AO; Lessey, BA; Satyaswaroop, PG; Somkuti, SG; Yuan, L | 1 |
Van Look, PF; von Hertzen, H | 1 |
Gurpide, E; Markiewicz, L | 1 |
Hyder, SM; Murthy, L; Stancel, GM | 1 |
Levental, M; Martineau, PA | 1 |
Arnulfo, A; Baj, G; Boldorini, R; Malavasi, F; Nicosia, G; Surico, N; Villa, L | 1 |
Kovács, L; Zalányi, S | 1 |
Arnold, JT; Kaufman, DG; Lessey, BA; Seppälä, M | 1 |
Distler, W; Vering, A | 1 |
4 review(s) available for mifepristone and Cancer of Endometrium
Article | Year |
---|---|
Current and future medical treatments for menometrorrhagia during the premenopause.
Topics: Adolescent; Adult; Contraceptives, Oral; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Metrorrhagia; Mifepristone; Norpregnadienes; Polyps; Premenopause; Progestins; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2011 |
Clinical uses of antiprogestogens.
Topics: Abortion, Induced; Antineoplastic Agents; Breast Neoplasms; Contraception; Contraceptives, Oral, Synthetic; Endometrial Neoplasms; Endometriosis; Estrenes; Female; Gonanes; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Progestins; Prostaglandins; Receptors, Progesterone | 1995 |
[Effect of antigestagens on human reproduction].
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Abortion, Therapeutic; Contraceptives, Oral, Hormonal; Endometrial Neoplasms; Endometriosis; Female; Hormone Antagonists; Humans; Labor, Induced; Mifepristone; Pregnancy; Progesterone | 2001 |
[Progesterone antagonists--pharmacology and perspectives of use].
Topics: Abortion, Induced; Animals; Breast Neoplasms; Endometrial Neoplasms; Female; Humans; Infant, Newborn; Luteal Phase; Mifepristone; Neoplasms, Hormone-Dependent; Pregnancy; Progesterone; Tumor Cells, Cultured | 1992 |
1 trial(s) available for mifepristone and Cancer of Endometrium
Article | Year |
---|---|
[Study on the treatment of high dose mifepristone and progesterone in endometrial carcinoma].
Topics: Adult; Aged; Drug Therapy, Combination; Endometrial Neoplasms; Female; Glycoproteins; Humans; Hyaluronan Receptors; Middle Aged; Mifepristone; Progesterone; Proliferating Cell Nuclear Antigen; Receptors, Estrogen; Receptors, Progesterone | 2003 |
26 other study(ies) available for mifepristone and Cancer of Endometrium
Article | Year |
---|---|
MPA alters metabolic phenotype of endometrial cancer-associated fibroblasts from obese women via IRS2 signaling.
Topics: Acetates; Cancer-Associated Fibroblasts; Endometrial Neoplasms; Female; Glucose; Humans; Insulin Receptor Substrate Proteins; Medroxyprogesterone Acetate; Mifepristone; Neoplasm Recurrence, Local; Obesity; Phenotype; Progesterone; Receptors, Progesterone; RNA, Messenger | 2022 |
Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium.
Topics: Cancer-Associated Fibroblasts; CDC2 Protein Kinase; Drug Resistance, Neoplasm; Endometrial Neoplasms; Endometrium; Female; Humans; Luciferases; Medroxyprogesterone Acetate; Mifepristone; Neoplasms; Receptors, Progesterone; RNA, Messenger; Up-Regulation | 2022 |
First case report of acute generalized exanthematous pustulosis (AGEP) caused by mifepristone.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Anti-Inflammatory Agents; Dermatologic Agents; Dexamethasone; Endometrial Neoplasms; Female; Hormone Antagonists; Humans; Hysteroscopy; Mifepristone; Polyps; Progestins | 2020 |
Changes in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencing.
Topics: Cell Line, Tumor; Endometrial Neoplasms; Estrogens; Female; Gene Expression Profiling; GTP-Binding Proteins; Humans; Membrane Proteins; Mifepristone; Mitochondrial Proteins; Neoplasm Proteins; Progesterone; Receptors for Activated C Kinase; Receptors, Cell Surface; Tamoxifen; Transcriptome | 2013 |
[Mifepristone inhibites the migration of endometrial cancer cells through regulating H19 methylation].
Topics: Antigens, CD; Cadherins; Carcinoma; Cell Line, Tumor; Cell Movement; DNA Methylation; Down-Regulation; Endometrial Neoplasms; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; HMGA2 Protein; Humans; Mifepristone; Promoter Regions, Genetic; RNA, Long Noncoding; RNA, Messenger; Up-Regulation; Vimentin | 2016 |
Early effects of high concentrations of progesterone and mifepristone A gene expression study of endometrial cancer cells (Ishikawa).
Topics: Cell Line, Tumor; Down-Regulation; Endometrial Neoplasms; Epidermal Growth Factor; Female; Gene Expression Regulation, Neoplastic; Humans; Mifepristone; Progesterone; Progestins; Receptors, Progesterone; Up-Regulation | 2009 |
High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Contraceptives, Oral, Synthetic; Drug Synergism; Endometrial Neoplasms; Female; Flow Cytometry; Humans; Mifepristone; Progesterone; Progestins | 2009 |
Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Synergism; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Medroxyprogesterone; Mifepristone; Progesterone; Progestins; Receptors, Progesterone | 2009 |
p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
Topics: Breast Neoplasms; Cell Line, Tumor; Endometrial Neoplasms; Female; Gonanes; Humans; Ligands; MAP Kinase Kinase Kinase 1; Mifepristone; Mitogen-Activated Protein Kinase 1; Models, Biological; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phosphoserine; Promegestone; Proteasome Endopeptidase Complex; Protein Isoforms; Protein Stability; Receptors, Progesterone; Transcription, Genetic | 2011 |
Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Medroxyprogesterone; Mifepristone; Promegestone; Receptors, Progesterone; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone.
Topics: Adenocarcinoma; Cell Line; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Endometrial Neoplasms; Endometrium; Epithelial Cells; Estradiol; Female; Gene Expression; Hormone Antagonists; Humans; Mifepristone; Progesterone; RNA, Messenger; Thrombospondin 1; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2004 |
[Effects of estrogen, progestin and mifepristone on endometrial carcinoma cell lines].
Topics: Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Estradiol; Female; Humans; Mifepristone; Progesterone; Uterine Neoplasms | 2005 |
Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Female; Humans; Mifepristone | 2005 |
Stimulation of CEACAM1 expression by 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophore A23187 in endometrial carcinoma cells.
Topics: Anti-Bacterial Agents; Antigens, CD; Calcimycin; Carcinoma; Cell Adhesion Molecules; Endometrial Neoplasms; Estradiol; Female; Hormone Antagonists; Humans; Interferon-gamma; Medroxyprogesterone Acetate; Mifepristone; Phorbol Esters; Protein Kinase C; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2006 |
[Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
Topics: Adenocarcinoma; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Estradiol; Female; Humans; Mifepristone; Oligodeoxyribonucleotides, Antisense; Promegestone; Receptors, Progesterone; Transfection | 2006 |
In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines.
Topics: Apoptosis; Cell Line, Tumor; Cyclooxygenase 2; Endometrial Neoplasms; Female; Flow Cytometry; Hormone Antagonists; Humans; Immunohistochemistry; Inhibitory Concentration 50; Mifepristone; Proto-Oncogene Proteins c-bcl-2; Receptors, Steroid; Tumor Suppressor Protein p53 | 2008 |
Interaction between steroid hormones and endometrial opioids.
Topics: Adenocarcinoma; Animals; beta-Endorphin; Blotting, Northern; Dexamethasone; Dynorphins; Endometrial Neoplasms; Estradiol; Female; Hormones; Humans; Male; Mifepristone; Potassium Chloride; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured | 1994 |
Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone.
Topics: Adenocarcinoma; Endometrial Neoplasms; Estrone; Female; Humans; Mifepristone; Progesterone; RNA, Messenger; Sulfates; Sulfotransferases; Tumor Cells, Cultured | 1996 |
Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Base Sequence; Cell Line; Endometrial Neoplasms; Female; Haplorhini; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Molecular Sequence Data; Promoter Regions, Genetic; Receptors, Estrogen; Receptors, Progesterone; Transcription Factor AP-1; Transfection; Tumor Cells, Cultured | 1996 |
Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells.
Topics: Adenocarcinoma; Corticotropin-Releasing Hormone; Cyclic AMP; Dexamethasone; Dinoprostone; Endometrial Neoplasms; Endometrium; Epidermal Growth Factor; Estradiol; Female; Gene Expression Regulation; Humans; Indomethacin; Luciferases; Mifepristone; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 1996 |
Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin.
Topics: Adenocarcinoma; Endometrial Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Integrin alpha1beta1; Integrins; Mifepristone; Neoplasm Proteins; Progesterone; Protein Biosynthesis; Receptors, Progesterone; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Tumor Cells, Cultured | 1996 |
Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.
Topics: Adenocarcinoma; Alkaline Phosphatase; Androgen Antagonists; Androgens; Breast Neoplasms; Cyproterone Acetate; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Flutamide; Gonanes; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Testosterone; Testosterone Congeners; Tumor Cells, Cultured | 1997 |
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Large endometrial polyp in a patient on long-term mifepristone therapy.
Topics: Endometrial Neoplasms; Female; Hormone Antagonists; Humans; Meningeal Neoplasms; Meningioma; Middle Aged; Mifepristone; Polyps; Progesterone; Ultrasonography | 2000 |
Hormonal modulation of GM-CSF receptor alpha-chain in in vitro models of endometrial cancer.
Topics: Dose-Response Relationship, Drug; Down-Regulation; Endometrial Neoplasms; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Mifepristone; Progesterone; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Tumor Cells, Cultured | 2000 |
Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Basement Membrane; Cell Communication; Cell Differentiation; Cell Division; Coculture Techniques; Collagen; Culture Media; Drug Combinations; Endometrial Neoplasms; Endometrium; Estrogens; Female; Glycodelin; Glycoproteins; Humans; Laminin; Mifepristone; Pregnancy Proteins; Progesterone; Proteoglycans; Stromal Cells; Tissue Extracts | 2002 |